ID: ALA2311985

Max Phase: Preclinical

Molecular Formula: C25H34N2O4

Molecular Weight: 426.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCCCCCOc1ccc2oc3ccc(OCCCCCCN)cc3c(=O)c2c1

Standard InChI:  InChI=1S/C25H34N2O4/c26-13-5-1-3-7-15-29-19-9-11-23-21(17-19)25(28)22-18-20(10-12-24(22)31-23)30-16-8-4-2-6-14-27/h9-12,17-18H,1-8,13-16,26-27H2

Standard InChI Key:  PCXSGILLBJCPIV-UHFFFAOYSA-N

Associated Targets(Human)

Endoribonuclease Dicer 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 426.56Molecular Weight (Monoisotopic): 426.2519AlogP: 4.74#Rotatable Bonds: 14
Polar Surface Area: 100.71Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.51CX LogP: 3.98CX LogD: -1.23
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.29Np Likeness Score: 0.10

References

1. Murata A, Fukuzumi T, Umemoto S, Nakatani K..  (2013)  Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: targeting secondary structures of pre-miRNA by small molecules.,  23  (1): [PMID:23164709] [10.1016/j.bmcl.2012.10.108]

Source